Stay updated on Nivolumab and Metformin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Metformin in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior notice about government funding lapse and the operating-status details (Revision: v3.4.1). These changes are administrative and do not affect study data or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide government funding notice with links to cc.nih.gov and opm.gov; updated page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedShow glossary has been added, and metadata labels have been adjusted (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), with a new revision tag 'Revision: v3.4.0'.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a Locations section with Illinois as a location and updated the page revision to v3.3.3; HHS Vulnerability Disclosure was removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and Metformin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.